Open AccessBoarding issue in a commercial flight for patients with cavitary pulmonary tuberculosis: A case report
Author(s) -
Woori Jo,
Chuiyong Pak,
Yangjin Jegal,
Kwang Won Seo
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i3.546
Subject(s) - medicine , pulmonary tuberculosis , sputum , tuberculosis , air travel , airborne transmission , mycobacterium tuberculosis , intensive care medicine , transmission (telecommunications) , surgery , infectious disease (medical specialty) , covid-19 , pathology , disease , aviation , electrical engineering , engineering , aerospace engineering
Several studies have demonstrated that airborne transmission of Mycobacterium tuberculosis bacteria from patients with active pulmonary tuberculosis (TB) to other passengers or crew members can occur during long flights. As such, non-infectious TB patients are usually allowed to undertake air travel after taking the appropriate anti-TB drugs. However, the global guidelines for air travel for patients with TB are inconsistent and insufficiently detailed with respect to cavitary pulmonary TB (CPTB).